Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$30.07 USD
+0.76 (2.59%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $30.25 +0.18 (0.60%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth C Momentum D VGM
Earnings News For SUPN
-
Supernus: Q4 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
-
Supernus: Q3 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Supernus Pharmaceuticals (SUPN) Reports Q2 Loss, Misses Revenue Estimates
-
Supernus: Q2 Earnings Snapshot
-
Supernus: Q1 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates
-
Supernus: Q4 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates
-
Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: Should You Buy?
-
Supernus Pharmaceuticals (SUPN) Misses Q3 Earnings Estimates
-
Supernus: Q3 Earnings Snapshot
-
Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Beat Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates
-
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
-
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Miss Estimates
-
Supernus Pharmaceuticals (SUPN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Surpass Estimates
-
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates